[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100220916":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":11,"locations":24,"responsibleParty":46,"collaborators":11,"id":50,"slug":11,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":11,"enrollmentInfo":59,"targetDuration":11,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":11,"overallStatus":27,"whyStopped":11,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Implantable loop recorders Reveal ICM LINQ®,","EXPERIMENTAL",null,[13],"Device: Implantable loop recorders system Reveal ICM LINQ®,",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":11},"DEVICE","Implantable loop recorders system Reveal ICM LINQ®,",[9],[20],{"name":21,"affiliation":22,"role":23},"Josep Rodes, MD","Fondation IUCPQ","PRINCIPAL_INVESTIGATOR",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"IUCPQ","RECRUITING","Québec","Quebec","G1V 4G5","Canada","CA",{"type":34,"coordinates":35},"Point",[36,37],-71.21454,46.81228,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Emilie Pelletier Beaumont, M.Sc.","CONTACT","418-656-8711","3929","Emilie.Pelletier-Beaumont@criucpq.ulaval.ca",{"type":23,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":49,"oldNameTitle":11,"oldOrganization":11},"Josep Rodes-Cabau","MD","Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","100220916",false,"NCT02153307","Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The \"MARE\" Study","MARE","Inclusion Criteria:\n\n-Patients undergoing TAVI with either balloon or self-expandable valves who develop new-onset LBBB persistent at hospital discharge, at least 3 days after the procedure\n\nExclusion Criteria:\n\n* Failure to provide informed consent\n* Baseline pacemaker\u002Fdefibrillator or pacemaker\u002Fdefibrillator implanted during the hospitalization period following the TAVI procedure\n* Pre-existing complete LBBB\n* Patients with a life-expectancy of less than 2 years",true,"ALL","18 Years",{"count":60,"type":61},80,"ESTIMATED","INTERVENTIONAL",[64],"NA","The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve implantation (TAVI) and to evaluate the usefulness of the Reveal LINQ® insertable Cardiac Monitor (ICM) (Medtronic, Inc., Minneapolis, USA) for the detection of significant arrhythmias in patients with NOP-LBBB following TAVI.",[67,68],"Aortic Valve Disease","Conduction Disturbances","2026-03-23",{"date":71,"type":72},"2026-03-24","ACTUAL",{"date":74,"type":11},"2014-01",{"date":76,"type":61},"2026-07",{"name":49,"class":6},1]